A biotin-avidin-based enzyme immunoassay for beta h-endorphin

Area of Science:

• Biochemistry
• Immunology
• Assay Development

Background:

• Beta-human endorphin (beta h-EP) is a crucial endogenous opioid peptide.
• Accurate quantification of beta h-EP is essential for physiological and pathological studies.
• Existing methods like radioimmunoassays (RIAs) have limitations in sensitivity or require specialized handling.

Purpose of the Study:

• To develop and validate a sensitive and reliable avidin-biotin enzyme-linked immunosorbent assay (ELISA) for beta h-EP.
• To compare the performance of the developed ELISA with established RIA methods.
• To demonstrate the utility of the ELISA for quantifying beta h-EP in biological samples.

Main Methods:

• Utilized microtiter plates with specific antibodies and biotinylated beta h-EP tracer derivatives.
• Employed a sequential saturation procedure with high-affinity antiserum and avidin-alkaline phosphatase complex.
• Blocked nonspecific binding using a casein and ethanolamine mixture.
• Validated the assay's sensitivity, precision (intra- and interassay coefficients of variation), and correlation with RIA.

Main Results:

• Achieved a detection limit of 0.5 fmol/assay, comparable to RIAs.
• Demonstrated high precision with intra-assay (5%) and interassay (12%) coefficients of variation.
• Showed excellent correlation with RIA results (r = 0.95).
• Successfully quantified beta h-EP in rat plasma (1600 fmol/mol) after HPLC fractionation.

Conclusions:

• The developed avidin-biotin ELISA is a sensitive, precise, and reliable method for beta h-EP quantification.
• This ELISA offers a viable alternative to RIA, potentially with broader accessibility and ease of use.
• The assay is suitable for determining beta h-EP levels in complex biological matrices like plasma.